Amino Acid Infusion in Cardiac Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

August 1, 2026

Conditions
Acute Kidney InjuryCardiac Surgery
Interventions
DRUG

Travesol 10%

Travesol 10% (Baxter) will be administered to the post-intervention participants at a dose of 2g per kilogram of ideal body weight for up to 3 days or until the participant's discharge from the intensive care unit.

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER